Skip to main content
StreamVetree
Sign in
Internal MedicineCase series / Retrospective2 min read · distilled by Vetree AI

BSAVA Petsavers Article: Validation of an ELISA assay for measurement of the metabolite of serotonin, 5-hydroxyindole acetic acid (5-HIAA), in canine urine.

Castillo D, Swallow A, Williams T, Watson P · Journal of Small Animal Practice · 25 March 2026

Clinical bottom line

ELISA validates as reliable non-invasive alternative for measuring canine urinary 5-HIAA.

Summary

This study validates a commercially available ELISA assay for measuring 5-hydroxyindole acetic acid (5-HIAA), a urinary metabolite of serotonin, in dogs. Serotonin's short serum half-life makes direct measurement unreliable; therefore, measuring urinary 5-HIAA after an 8-hour fast provides a more stable indicator of circulating serotonin levels, similar to established protocols in human medicine. Urine samples from 26 dogs were analyzed using both ELISA and liquid chromatography-tandem mass spectrometry (the gold standard). The ELISA demonstrated acceptable precision and repeatability with a coefficient of variation below 20%. Bland-Altman and Deming regression analyses showed good agreement between methods, with minimal bias (0.92 μmol/L) and acceptable limits of agreement. However, the assay's reliability at upper analytical measurement range limits was not adequately tested. The authors conclude that ELISA is a reliable, non-invasive alternative to blood sampling, particularly at low concentrations, though high concentrations may exceed acceptable error margins. Further validation in normal and diseased dogs is necessary before clinical implementation.

Internal MedicineSmall AnimalPharmacologyPathology

This summary was distilled by AI and may occasionally misinterpret data. Confirm critical details with the primary literature before clinical application.